LOC107913963 Antibody

What is LOC107913963 and what is its role in plant biology?

LOC107913963 is a gene that encodes a B3 domain-containing transcription factor LEC2-like protein in Gossypium hirsutum (upland cotton). It belongs to the family of B3 domain transcription factors, which play crucial roles in plant development.

Based on sequence and structural bioinformatic analyses, this protein:

• Contains a conserved B3 transcription factor domain with DNA-binding residues

• Most closely clusters with REM subfamily members of B3-domain containing proteins

• Is predicted to localize to the nucleus

• May function similarly to other LEC2-type transcription factors that regulate embryonic development

The LEC2 transcription factors are particularly important in somatic embryogenesis in plants. Research indicates that LEC2 genes are upregulated in callus producing embryogenic callus (EC) and may function downstream in the auxin signaling pathway in somatic embryogenesis .

Why are researchers interested in antibodies against LOC107913963?

Researchers are interested in antibodies against LOC107913963 for several methodological reasons:

• Functional characterization: To study the protein's expression patterns during different developmental stages and in response to various stimuli.

• Protein localization: To confirm the predicted nuclear localization and examine any potential dynamic changes in subcellular distribution.

• Protein-protein interactions: To identify binding partners that may provide insights into the transcriptional regulatory networks.

• Chromatin immunoprecipitation (ChIP): To determine DNA binding sites and target genes regulated by this transcription factor.

• Somatic embryogenesis research: Given the similarity to LEC2, which is crucial for embryogenic callus formation, antibodies can help track expression during tissue culture and regeneration processes .

What types of LOC107913963 antibodies are available for research applications?

Several types of antibodies against LOC107913963 are commercially available for research purposes:

The antibodies are typically generated using recombinant LOC107913963 protein fragments as immunogens. For example, one commercial antibody uses a recombinant protein fragment corresponding to amino acids 1-166 as the immunogen .

What are the recommended protocols for using LOC107913963 antibodies in Western blotting?

When using LOC107913963 antibodies for Western blotting in plant research, follow these methodological guidelines:

• Sample preparation:

  • Extract nuclear proteins from plant tissues using a dedicated nuclear extraction buffer (e.g., 20mM HEPES pH 7.5, 400mM NaCl, 1mM EDTA, 1mM DTT, 1mM PMSF, protease inhibitor cocktail)

  • Include phosphatase inhibitors if studying potential post-translational modifications

  • Use fresh tissue whenever possible or snap-freeze in liquid nitrogen

• Protein separation:

  • Use 10% SDS-PAGE gels for optimal separation (LOC107913963 has a predicted molecular weight of ~56.3 kDa)

  • Include positive controls (recombinant LOC107913963 protein) and negative controls

• Transfer and blocking:

  • Transfer to PVDF membrane (recommended over nitrocellulose for nuclear proteins)

  • Block with 5% non-fat milk or BSA in TBS-T for 1 hour at room temperature

• Antibody incubation:

  • Primary antibody dilution: 1:500-1:2000 (optimize for each lot)

  • Incubate overnight at 4°C

  • Secondary antibody: Anti-rabbit HRP conjugate at 1:5000-1:10000

  • Include proper washing steps (3-5 times, 5-10 minutes each with TBS-T)

• Detection:

  • Use enhanced chemiluminescence (ECL) detection system

  • For low abundance proteins, consider using signal enhancement systems

How should researchers optimize immunofluorescence protocols with LOC107913963 antibodies?

For immunofluorescence applications with LOC107913963 antibodies in plant tissues:

• Tissue fixation and preparation:

  • Fix tissue samples in 4% paraformaldehyde for 1-2 hours

  • For cotton tissues, extend fixation time to ensure proper penetration

  • Perform cell wall digestion with enzymes (cellulase/pectinase mixture) for better antibody accessibility

  • Consider using vibratome sections (50-100μm) for intact tissue architecture

• Antigen retrieval:

  • Heat-mediated antigen retrieval (citrate buffer pH 6.0) may improve signal for nuclear proteins

  • For recalcitrant plant tissues, try detergent permeabilization (0.1-0.5% Triton X-100)

• Blocking and antibody incubation:

  • Block with 3-5% BSA in PBS with 0.1% Triton X-100

  • Use FITC-conjugated LOC107913963 antibodies at 1:50-1:200 dilution

  • For unconjugated primary antibodies, use appropriate fluorophore-labeled secondary antibodies

  • Extend incubation times (24-48 hours at 4°C) for better penetration in plant tissues

• Controls:

  • Include no-primary antibody controls

  • Use tissues with known expression patterns or transgenic lines with altered expression

  • Counter-stain nuclei with DAPI to confirm nuclear localization

• Imaging:

  • Use confocal microscopy for better resolution of nuclear localization

  • Capture Z-stack images to document the three-dimensional distribution

What considerations are important for sample preparation when studying LOC107913963?

When preparing samples for LOC107913963 studies, consider the following methodological approaches:

• Developmental timing:

  • LEC2-like transcription factors show dynamic expression during embryogenesis and callus formation

  • Collect samples at multiple developmental stages (especially during somatic embryogenesis)

  • Compare expression between callus capable and incapable of forming embryogenic callus

• Tissue selection:

  • Focus on tissues with active cell division and differentiation

  • Include comparisons between embryogenic and non-embryogenic tissues

  • Consider isolation of specific cell types through laser capture microdissection

• Protein extraction considerations:

  • Use specialized nuclear extraction protocols to enrich for transcription factors

  • Include protease inhibitors freshly prepared before extraction

  • Minimize sample processing time to reduce protein degradation

  • Consider crosslinking for protein-protein interaction studies

• Storage conditions:

  • Store tissue samples in RNAlater for parallel RNA expression analysis

  • Flash-freeze protein extracts and store at -80°C

  • Avoid repeated freeze-thaw cycles

How can ChIP-seq be optimized for studying LOC107913963 binding sites?

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is a powerful method to identify genome-wide binding sites for transcription factors like LOC107913963. Here's a methodological approach:

• Sample preparation:

  • Use fresh tissue with verified LOC107913963 expression

  • Crosslink with 1% formaldehyde for 10-15 minutes

  • For plant tissues, optimize crosslinking time (may require longer incubation)

  • Isolate nuclei before chromatin extraction to reduce background

• Chromatin shearing:

  • Sonicate to generate 200-500bp fragments

  • Verify shearing efficiency by agarose gel electrophoresis

  • Optimize sonication conditions for plant tissues (which are more resistant)

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Use 2-5μg of LOC107913963 antibody per sample

  • Include IgG control and input samples

  • Extend incubation time to 16-20 hours at 4°C with rotation

• DNA purification and library preparation:

  • Reverse crosslinking: incubate at 65°C for 6-16 hours

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Prepare libraries using standard ChIP-seq protocols

  • Include spike-in controls for quantitative analysis

• Data analysis:

  • Align reads to the Gossypium hirsutum reference genome

  • Use peak-calling algorithms (MACS2, Homer) to identify binding sites

  • Perform motif enrichment analysis to identify binding motifs

  • Integrate with RNA-seq data to correlate binding with gene expression

What approaches can researchers use to study the role of LOC107913963 in somatic embryogenesis?

To investigate the role of LOC107913963 in somatic embryogenesis, researchers should consider these methodological approaches:

• Expression profiling:

  • Compare LOC107913963 protein and mRNA levels between cotton cultivars with different EC differentiation rates

  • Track expression changes during callus induction and EC formation

  • Compare with other LEC genes known to be involved in somatic embryogenesis

• Functional studies:

  • Generate transgenic cotton with altered LOC107913963 expression

  • Consider using the Wus-mediated system to enhance EC formation as described for other LEC genes

  • Monitor effects on embryogenic callus formation and regeneration

• Protein-protein interactions:

  • Perform co-immunoprecipitation with LOC107913963 antibodies

  • Identify protein complexes involved in transcriptional regulation

  • Investigate interactions with auxin signaling components

• Target gene identification:

  • Combine ChIP-seq with RNA-seq to identify direct targets

  • Focus on genes involved in auxin signaling and embryogenesis

  • Validate key targets using reporter gene assays

• Comparative analysis:

  • Compare results with those from model plants like Arabidopsis

  • Investigate the conservation of LEC2 function across plant species

  • Create a regulatory network model for somatic embryogenesis

How can researchers validate the specificity of LOC107913963 antibodies?

Validating antibody specificity is crucial for reliable research. For LOC107913963 antibodies, consider these methodological approaches:

• Western blot validation:

  • Test against recombinant LOC107913963 protein

  • Compare signal between tissues with high and low expression

  • Test in tissues from RNAi or CRISPR knockdown lines (if available)

  • Perform peptide competition assay using the immunizing peptide

• Immunoprecipitation validation:

  • Perform IP followed by mass spectrometry to confirm target identity

  • Analyze peptide coverage across the target protein

  • Check for co-immunoprecipitating proteins that might be specific interactors

• Cross-reactivity assessment:

  • Test against closely related B3 domain proteins

  • Perform sequence alignment to identify potential cross-reactive epitopes

  • Consider testing in heterologous expression systems

• Immunohistochemistry controls:

  • Compare staining patterns with mRNA expression data

  • Use blocking peptides to confirm signal specificity

  • Include negative controls (pre-immune serum, isotype controls)

• Knockout/knockdown validation:

  • Test antibody in tissues with genetically reduced target expression

  • Compare with overexpression systems to confirm signal correlation with expression levels

How should researchers address non-specific binding when using LOC107913963 antibodies?

When encountering non-specific binding with LOC107913963 antibodies, implement these methodological solutions:

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, milk, normal serum, commercial blockers)

  • Increase blocking time (2-3 hours at room temperature or overnight at 4°C)

  • Add 0.1-0.5% Tween-20 or Triton X-100 to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Perform a dilution series to find optimal concentration

  • Consider extended incubation at higher dilutions (1:2000-1:5000)

  • Reduce primary antibody concentration if background is high

• Stringent washing:

  • Increase number and duration of wash steps

  • Use higher salt concentration in wash buffers (up to 500mM NaCl)

  • Add 0.1% SDS to wash buffer for stubborn background

• Sample preparation improvements:

  • Pre-clear lysates with protein A/G beads before immunoprecipitation

  • Use nuclear extraction methods to enrich for the target protein

  • Consider additional purification steps like size exclusion or ion exchange

• Alternative detection methods:

  • Switch from colorimetric to fluorescent or chemiluminescent detection

  • Use highly cross-adsorbed secondary antibodies

  • Consider signal amplification systems for specific signal enhancement

What are common causes for weak or no signal when using LOC107913963 antibodies?

When experiencing weak or absent signals with LOC107913963 antibodies, consider these methodological troubleshooting steps:

• Protein expression and extraction issues:

  • Verify target expression using RT-PCR or RNA-seq data

  • LEC2-like proteins may have tissue-specific or development-specific expression

  • Use specialized extraction buffers for nuclear proteins (high salt, detergents)

  • Add protease inhibitors to prevent degradation

• Antibody-related issues:

  • Check antibody storage conditions and expiration date

  • Avoid repeated freeze-thaw cycles of antibody aliquots

  • Verify antibody reactivity with positive controls (recombinant protein)

  • Consider epitope masking due to protein folding or post-translational modifications

• Technical considerations:

  • For Western blots: ensure complete transfer by using stain-free gels or Ponceau staining

  • For IF/IHC: optimize antigen retrieval methods for nuclear proteins

  • Increase antibody incubation time (overnight at 4°C for primary antibody)

  • Try different detection systems with higher sensitivity

• Sample-specific issues for plant tissues:

  • Plant tissues may contain compounds that interfere with antibody binding

  • Include PVPP or activated charcoal in extraction buffers to remove phenolics

  • Use specialized plant protein extraction buffers containing DTT or β-mercaptoethanol

  • Consider using younger tissues with less accumulated secondary metabolites

How can researchers analyze contradictory results from different experiments using LOC107913963 antibodies?

When faced with contradictory results using LOC107913963 antibodies, apply these analytical methods:

• Systematic comparison of experimental conditions:

  • Create a detailed table comparing all experimental variables

  • Identify key differences in protocols, reagents, and sample preparation

  • Standardize critical parameters across experiments

  Experiment Parameter	Experiment 1	Experiment 2	Experiment 3
  Antibody lot	A123	A123	B456
  Antibody dilution	1:1000	1:500	1:1000
  Tissue type	Callus	Embryo	Callus
  Extraction method	TRIzol	Nuclear	RIPA
  Detection system	ECL	Fluorescent	ECL Plus
  Incubation time	1 hour	Overnight	2 hours

• Control and validation analysis:

  • Review all controls to ensure they performed as expected

  • Implement additional validation experiments (peptide competition, knockdown)

  • Consider using alternative antibodies or detection methods

• Biological context evaluation:

  • Analyze the biological context of each experiment

  • Consider developmental timing, tissue specificity, and experimental treatments

  • Review the literature for similar observations with related proteins

• Statistical analysis:

  • Perform statistical analyses on quantitative data

  • Consider power analysis to determine if sample size is adequate

  • Implement appropriate statistical tests for the experimental design

• Independent validation methods:

  • Confirm protein expression with orthogonal methods (mass spectrometry)

  • Correlate protein detection with mRNA expression data

  • Consider reporter systems to track expression patterns independently

What essential controls should be included in experiments using LOC107913963 antibodies?

To ensure experimental rigor when using LOC107913963 antibodies, include these essential controls:

• Positive controls:

  • Recombinant LOC107913963 protein (available commercially)

  • Tissues known to express high levels of the target (based on RNA-seq data)

  • Overexpression systems if available

• Negative controls:

  • Primary antibody omission

  • Isotype control antibody at equivalent concentration

  • Pre-immune serum (for polyclonal antibodies)

  • Tissues known to have low/no expression of target

• Specificity controls:

  • Peptide competition assay using immunizing antigen

  • Knockdown/knockout tissues if available

  • Testing in heterologous expression systems

• Technical controls:

  • Loading controls for Western blots (housekeeping proteins)

  • Nuclear marker controls for localization studies

  • Process controls (carried through entire protocol without sample)

• Quantification controls:

  • Standard curves with recombinant protein for quantitative applications

  • Spike-in controls for normalization

  • Dilution series to ensure signal linearity

By implementing these controls, researchers can increase confidence in results and address potential issues in experimental design and execution.

How might new antibody technologies enhance LOC107913963 research?

Emerging antibody technologies offer promising approaches for advancing LOC107913963 research:

• Nanobody development:

  • Single-domain antibodies derived from camelid species provide advantages for plant research

  • Their small size (10× smaller than conventional antibodies) allows better tissue penetration

  • Higher stability and specificity make them ideal for challenging plant tissues

  • Potential for intracellular targeting to study LOC107913963 in living cells

• Recombinant antibody engineering:

  • Creating antibodies with common CDRH3 motifs for enhanced specificity

  • Developing antibodies with reduced cross-reactivity to related B3 domain proteins

  • Engineering antibodies optimized for specific applications (ChIP, IF, WB)

• Multiplexed antibody approaches:

  • Simultaneous detection of multiple B3 domain transcription factors

  • Co-detection of LOC107913963 with interaction partners

  • Proximity ligation assays to map protein-protein interactions in situ

• Active learning for antibody optimization:

  • Implementation of machine learning approaches for predicting antibody-antigen binding

  • Iterative improvement of antibody binding properties

  • Library-on-library screening to identify optimal antibody variants

What research gaps exist in our understanding of LOC107913963 and how can antibody technology address them?

Several research gaps exist in our understanding of LOC107913963, which can be addressed using antibody technologies:

• Functional characterization:

  • The precise role of LOC107913963 in cotton development remains poorly understood

  • Antibodies can help track expression patterns across tissues and developmental stages

  • ChIP-seq with validated antibodies can map genome-wide binding sites

• Regulatory network mapping:

  • The target genes and regulatory partners of LOC107913963 are unknown

  • Immunoprecipitation combined with mass spectrometry can identify protein complexes

  • Sequential ChIP (ChIP-reChIP) can identify co-occupied genomic regions

• Post-translational modifications:

  • Potential modifications that regulate LOC107913963 activity are unexplored

  • Modification-specific antibodies can track regulatory changes

  • Phospho-specific antibodies might reveal activation patterns

• Structure-function relationships:

  • The detailed structural features that determine DNA binding specificity are unknown

  • Epitope-specific antibodies can help map functional domains

  • Conformation-specific antibodies might distinguish active from inactive states